Hester Biosciences Ltd posts Rs. 3.98 crore consolidated profit in Q3 FY24

Hester Biosciences Limited has reported Consolidated financial results for the period ended December 31, 2023.

Financial Results (Q3 FY2024) - QoQ Comparison

The company has reported total income of Rs. 67.973 crores during the period ended December 31, 2023 as compared to Rs. 74.813 crores during the period ended September 30, 2023.

The company has posted net profit / (loss) of Rs. 3.984 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs. 4.086 crores for the period ended September 30, 2023.

The company has reported EPS of Rs. 4.76 for the period ended December 31, 2023 as compared to Rs. 4.75 for the period ended September 30, 2023.

Financials	Q3 FY2024	Q2 FY2024	% Change
Total Income	₹ 67.973 crs	₹74.813 crs	-9.14%
Net Profit	₹3.984 crs	₹4.086 crs	-2.50%
EPS	₹4.76	₹4.75	0.21%

Financial Results (Q3 FY2024) - YoY Comparison

The company has reported total income of Rs. 67.973 crores during the period ended December 31, 2023 as compared to Rs.79.335 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.3.984 crores for the period ended December 31, 2023 as against net profit / (loss) of Rs.11.186 crores for the period ended December 31, 2022.

The company has reported EPS of Rs.4.76 for the period ended December 31, 2023 as compared to Rs.14.29 for the period ended December 31, 2022.

Financials	Q3 FY2024	Q3 FY2023	% Change
Total Income	₹ 67.973 crs	₹79.335 crs	-14.32%
Net Profit	₹3.984 crs	₹11.186 crs	-64.38%
EPS	₹4.76	₹14.29	-66.69%

Financial Results (9 Months Ended FY2024) - YoY Comparison

The company has reported total income of Rs.231.784 crores during the 9 Months period ended December 31, 2023 as compared to Rs.210.755 crores during the 9 Months period ended December 31, 2022.

The company has posted net profit / (loss) of Rs.13.939 crores for the 9 Months period ended December 31, 2023 as against net profit / (loss) of Rs.22.096 crores for the 9 Months period ended December 31, 2022.

The company has reported EPS of Rs.17.36 for the 9 Months period ended December 31, 2023 as compared to Rs.26.24 for the 9 Months period ended December 31, 2022.

Financials	9 Months Ended FY2024	9 Months Ended FY2023	% Change
Total Income	₹231.784 crs	₹210.755 crs	9.98%
Net Profit	₹13.939 crs	₹22.096 crs	-36.92%
EPS	₹17.36	₹26.24	-33.84%

Shares of Hester Biosciences Limited was last trading in BSE at Rs. 1471.60 as compared to the previous close of Rs. 1519.30. The total number of shares traded during the day was 1023 in over 276 trades.

The stock hit an intraday high of Rs. 1520.00 and intraday low of 1420.75. The net turnover during the day was Rs. 1499617.00.

Source : Equity Bulls

Keywords

HesterBiosciences Q3FY24 9MFY24 ResultUpdate